Shanghai Haohai Biological Technology Co Ltd
SSE:688366

Watchlist Manager
Shanghai Haohai Biological Technology Co Ltd Logo
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Watchlist
Price: 62.46 CNY -6.09% Market Closed
Market Cap: 12B CNY
Have any thoughts about
Shanghai Haohai Biological Technology Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Shanghai Haohai Biological Technology Co Ltd

Revenue
2.7B CNY
Cost of Revenue
-833.4m CNY
Gross Profit
1.9B CNY
Operating Expenses
-1.4B CNY
Operating Income
464.2m CNY
Other Expenses
-18.1m CNY
Net Income
446.2m CNY

Income Statement
Shanghai Haohai Biological Technology Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
1 615
N/A
1 604
-1%
1 446
-10%
1 315
-9%
1 352
+3%
1 332
-1%
1 561
+17%
1 688
+8%
1 715
+2%
1 767
+3%
1 858
+5%
1 884
+1%
2 075
+10%
2 130
+3%
2 268
+6%
2 475
+9%
2 530
+2%
2 654
+5%
2 689
+1%
2 746
+2%
Gross Profit
Cost of Revenue
(383)
(365)
(333)
(302)
(322)
(338)
(404)
(449)
(467)
(492)
(566)
(582)
(652)
(669)
(692)
(762)
(762)
(790)
(823)
(833)
Gross Profit
1 232
N/A
1 240
+1%
1 113
-10%
1 013
-9%
1 030
+2%
995
-3%
1 157
+16%
1 238
+7%
1 248
+1%
1 275
+2%
1 292
+1%
1 302
+1%
1 422
+9%
1 461
+3%
1 576
+8%
1 713
+9%
1 767
+3%
1 864
+6%
1 866
+0%
1 912
+2%
Operating Income
Operating Expenses
(829)
(889)
(902)
(925)
(947)
(872)
(888)
(852)
(881)
(1 041)
(1 089)
(1 217)
(1 285)
(1 255)
(1 365)
(1 386)
(1 416)
(1 426)
(1 418)
(1 448)
Selling, General & Administrative
(757)
(765)
(828)
(855)
(851)
(722)
(782)
(731)
(754)
(816)
(943)
(1 064)
(1 126)
(988)
(1 169)
(1 184)
(1 207)
(1 131)
(1 216)
(1 219)
Research & Development
(128)
(110)
(120)
(121)
(121)
(115)
(135)
(143)
(156)
(153)
(177)
(171)
(175)
(171)
(190)
(207)
(215)
(209)
(231)
(244)
Depreciation & Amortization
0
(60)
0
0
0
(68)
0
0
0
(103)
0
0
0
(134)
0
0
0
(125)
0
0
Other Operating Expenses
56
46
45
51
24
33
29
23
30
31
31
18
17
38
(6)
5
5
39
29
16
Operating Income
403
N/A
350
-13%
210
-40%
88
-58%
83
-6%
122
+48%
270
+120%
387
+43%
367
-5%
234
-36%
203
-13%
85
-58%
138
+62%
206
+50%
211
+2%
327
+55%
351
+7%
439
+25%
447
+2%
464
+4%
Pre-Tax Income
Interest Income Expense
85
95
110
131
147
137
134
136
133
150
135
122
100
74
65
58
62
68
62
57
Non-Reccuring Items
(1)
(10)
(0)
(0)
(1)
(1)
(0)
(0)
0
(0)
(0)
(0)
(0)
(47)
0
1
1
1
1
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(2)
(2)
(1)
(0)
(0)
(1)
2
2
2
2
1
(0)
(1)
Pre-Tax Income
485
N/A
434
-10%
319
-27%
218
-32%
228
+5%
257
+13%
402
+56%
520
+29%
498
-4%
383
-23%
338
-12%
206
-39%
237
+15%
236
0%
278
+18%
388
+40%
416
+7%
508
+22%
510
+0%
521
+2%
Net Income
Tax Provision
(62)
(58)
(45)
(26)
(21)
(31)
(48)
(69)
(60)
(35)
(26)
(21)
(37)
(45)
(66)
(63)
(65)
(96)
(91)
(100)
Income from Continuing Operations
424
376
274
192
207
226
354
451
438
347
311
184
199
190
212
325
351
412
420
421
Income to Minority Interest
(37)
(6)
6
24
26
4
(2)
(18)
(10)
5
5
8
4
(10)
(11)
(10)
(6)
4
13
25
Net Income (Common)
387
N/A
371
-4%
279
-25%
216
-23%
232
+8%
230
-1%
352
+53%
434
+23%
428
-1%
352
-18%
316
-10%
192
-39%
203
+6%
180
-11%
201
+11%
315
+57%
346
+10%
416
+20%
432
+4%
446
+3%
EPS (Diluted)
2.42
N/A
2.27
-6%
1.57
-31%
1.21
-23%
1.32
+9%
1.3
-2%
2
+54%
2.47
+24%
2.44
-1%
1.43
-41%
1.8
+26%
1.1
-39%
1.16
+5%
0.74
-36%
1.16
+57%
1.85
+59%
1.41
-24%
1.74
+23%
1.83
+5%
1.93
+5%

See Also

Discover More